TNFRSF11B and breast cancer: In a mouse xenograft model of metastatic human breast cancer, overexpression of wild-type ERRα-reduced metastasis and breast cancer cell growth in the bone, likely by upregulating the osteoclastogenesis inhibitor, osteoprotegerin (OPG).